Evaluation of Control Chart Impact on Surgical Outcomes

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This two arms parallel cluster-randomized trial will evaluate the impact of monitoring surgical outcomes using Shewhart control chart (intervention) on the occurence of major adverse events, among a large sample of French surgical departments. Trends in surgical outcomes before and after the intervention will be compared between arms.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03289975` - Early Identification of Patients in Surgical Intensive Care With a Risk of Acute Respiratory Distress Following Visceral Surgery	N/A

NCT number	NCT02569450
Study type	Observational
Source	Hospices Civils de Lyon
Contact
Status	Completed
Phase
Start date	October 2015
Completion date	December 31, 2018

Evaluation of Control Chart Impact on Surgical Outcomes — SHEWHART

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms